Your Presence is the Perfect Present For Mesothelioma Patients

This time of year everyone is rushing around hoping to make the holidays perfect. While that means something different to everyone – decorations, gifts, lots of food, or chocolaty desserts – for those suffering from mesothelioma it may just mean having their loved ones close by their side.

During the holiday season, feelings of sadness, loneliness and anxiety about an uncertain future for mesothelioma patients and their families are often accentuated leaving them depressed and overwhelmed. One thing that could lift your mood, and is within your control, is to simply take the time to revel in the enjoyment of your family and friends. Jennifer Gelsick, a “Faces of Mesothelioma” author, said on Friday that her father’s presence was the best present she had at Christmas, and just having his family home for the holidays buoyed her father’s spirits.

If you have a friend or a loved one who is sick over the holidays and you are not able to visit them, take the time to send a hand-written card or make a phone call to let them know you are thinking of them. In this day of technology, a personal touch can go a long way towards brightening someone’s day.

Sit back and try to enjoy the enjoy the simple pleasures of the holidays: the lights of the season, a light snow falling, a football game on TV, a fire in the fireplace or the bite of a delicious cookie. And, especially, the company of your family and friends. Remember that it is your presence that is the best present!

Happy holidays from all of us at MesotheliomaHelp.

Use of Nanoparticles in the Future May Gauge Progression of Mesothelioma, Increase Survival

Researchers have been tapping into nanoparticles, one of the newest cancer-fighting technologies, as a safe, effective means to treat cancers. MesotheliomaHelp has reported on the use of them as a microscopic drug delivery system to improve immunotherapy in mesothelioma patients. Now, one team of researchers reports they can use nanoparticles as a means to gauge whether a cancer is progressing by detecting even the smallest of tumors.

In hopes of finding an effective way to detect cancer cells in the earliest stages of metastases, researchers from Rutgers (https://news.rutgers.edu/faster-more-accurate-cancer-detection-using-nanoparticles-rutgers-led-study-finds/20171207#.WjF5q1WnHIU) University tested light-emitting nanoparticles in mice injected with human breast cancer cells. According to a Dec. 11 press release from Rutgers, the test was conducted using nanoprobes, or miniscule x-ray devices injected into the mice and carried through their bloodstream, allowing the researchers to “get a quick and reliable image of the location of affected cells in the body.”

“We’ve always had this dream that we can track the progression of cancer in real time, and that’s what we’ve done here. We’ve tracked the disease in its very incipient stages,” said Prabhas V. Moghe, a corresponding author of the study and distinguished professor of biomedical engineering and chemical and biochemical engineering at Rutgers–New Brunswick.

The researchers were able to distinguish even the tiniest of lesions and tumors just three to five weeks after the mice were injected. “The nanoprobes were significantly faster than MRIs at detecting” the growing cancer cells. Vidya Ganapathy, corresponding author and assistant research professor in the Department of Biomedical Engineering, believes this can translate to months when it comes to early detection of cancer in people.

Mesothelioma, an unusual form of cancer caused by exposure to airborne asbestos fibers, often has a complex growth pattern making complete surgical removal a very difficult task. Although the goal of the surgery is to achieve a macroscopically-complete resection, which refers to the removal of all visible tumor cells, determining if that was accomplished is not always possible.

“The Achilles’ heel of surgical management for cancer is the presence of micro metastases,” said Dr. Steven K. Libutti, director of Rutgers Cancer Institute of New Jersey. “The nanoprobes described in this paper will go a long way to solving these problems.”

The nanoparticles in this breakthrough discovery could be used to:

Detect cancer early;
Improve patient cure rates;
Improve cancer survival times;
Guide precise cancer treatment; and,
Limit cancer metastasis.

All of the above benefits are a win for mesothelioma patients who often suffer from the aggressive growth and spread of the asbestos-caused cancer. Survival times for mesothelioma patients are often limited to a year due to the inability to track the fast-growing cancer cells.

There is much more research to be done, however, the Rutgers team is hopeful that this technology will be useful on all types of cancer, including mesothelioma. They anticipate availability of the product within five years.

Read the full study in the Dec. 12 issue of the journal Nature Biomedical Engineering (https://www.nature.com/articles/s41551-017-0167-9).

“Powerful” Pain Reliever On the Horizon for Mesothelioma Patients

Mesothelioma patients often suffer from unbearable pain from which they rarely get a break. Whether it is pain from the tumors or treatment, patients report it is this pain that most impacts their quality of life. Now, researchers report they have found a “powerful” pain reliever that could change the lives of the millions of Americans suffering from chronic pain.

Read about a clinical trial being conducted to assess whether radiation therapy can be an effective form of pain relief for mesothelioma patients.

https://clinicaltrials.gov/ct2/show/NCT01991938

A team of researchers at the University of Texas at Austin made it their mission to find an effective pain reliever that is safe, effective and non-addictive. With opioid addiction a national crisis, the chemists, led by Stephen F. Martin, Professor, Department of Chemistry at UT, turned to the experimental drug UKH-1114. In a study of mice with nerve damage, the team discovered that one small dose lasted for days as compared to hours like other non-opioid drugs, according to an Aug. 16 press release announcing the findings.

http://www.prweb.com/recentnews

When compared to the widely-used drug gabapentin, an alternative to opioids, often prescribed for neuropathic (nerve) pain from chemotherapy, shingles and diabetes, UKH-1114 required just one-sixth the dose for the same relief and did not cause any cognitive impairment. The drug binds directly to receptors in the central nervous system called the sigma 2 receptor.

Sigma-2 receptors not only affect motor function and emotional response, they may also affect cell proliferation and immune response.

“This opens the door to having a new treatment for neuropathic pain that is not an opioid,” said Martin. “And that has huge implications.”

MesotheliomaHelp has reported numerous times on neuropathy from the chemotherapy that is given to nearly all mesothelioma patients. Patients trying to manage the well-known side effects of nausea and fatigue, are often caught off guard by the unforeseen pain of chemo-induced neuropathy. Chemotherapy can cause nerve damage, leading to shooting pain, burning, tingling, numbness, problems with balance and grasping things, as well as cold or heat sensitivity. Neuropathy can also result from radiation and surgery, or from the tumor itself.

According to the National Institutes of Health, nearly one-third of all cancer patients who receive chemotherapy will be affected by chemotherapy-induced peripheral neuropathy, and it is a leading reason why people with cancer stop chemotherapy early.

The researchers are still trying to get a grasp on how the sigma 2 receptor relieves pain, and they report that there is still more work to “demonstrate safety, efficacy and oral bioavailability” of UKH-1114 before taking it to market. But the team is “excited by the compelling results” from their research.

“We started out just working on fundamental chemistry in the lab,” said co-lead James Sahn, a research scientist in the Department of Chemistry. “But now we see the possibility that our discoveries could improve the quality of people’s lives. That is very satisfying.”

Read more about the study in the June 23, 2017, issue of ACS Chemical Neuroscience.

http://pubs.acs.org/doi/abs/10.1021/acschemneuro.7b00200

BAP1 Gene Research Opens Door to Mesothelioma Clinical Trial

For years, Michele Carbone, MD, PhD, and a team of researchers from the University of Hawaii Cancer Center have focused their mesothelioma research on the BAP1 gene. The researchers suspected that mutations of the BAP1 gene, which is involved in tumor suppression, might underlie mesothelioma in people with a strong family history of the disease. Now, in a recent study, the team has uncovered the mechanism behind the gene and what makes people with it more susceptible to developing cancers from environmental carcinogens, such as asbestos.

The researchers found that the BRCA1-associated protein 1, or BAP1, regulates a channel (IP3R3) inside cells that moves calcium. When the BAP1 gene is damaged, calcium levels decrease leaving the cells more apt to become malignant after environmental carcinogen exposure, according to June 14 press release from the University of Hawaii Cancer Center.

The study also led to the discovery in mouse models that this same effect left the cancer cells resistant to chemotherapy. Mesothelioma cells have an uncanny ability to fight off even the most toxic anti-cancer agents, allowing the cancer cells to spread and thrive.

Mesothelioma, a cancer caused by past asbestos exposure, is diagnosed in nearly 3,000 Americans each year. These people are faced with a long road of ups and downs after a seemingly successful cycle of chemotherapy ultimately fails and the cancer returns. Due to the aggressiveness of the cancer and its resistance to treatments, mesothelioma oncologists then turn to another chemotherapy to again attempt to quash the cancer.

Once the UH researchers found the “why” behind BAP1 the team turned to finding the “how” to fix the channel that can effectively lead to apoptosis, or death of the cancer cells, when treated with chemotherapy or other anti-cancer therapies. Once BAP1 levels are restored and the calcium channels are stabilized, treating cancer patients with the BAP1 mutation, and potentially preventing cancer in the first place, is feasible, according to the report. A clinical trial is in the works to test the findings.

“We want to prevent and treat cancer in as many people as possible,” said Dr. Carbone. “We hope to start a clinical trial, within five years or less, to test the susceptibility to chemotherapy in patients with BAP1 mutated tumors.”

Carbone notes that close to 20 percent of all cancers have BAP1 mutations, including 70 percent of mesothelioma cases and 90 percent of eye melanomas.

According to the National Institutes of Health, clinical trials are at the heart of all medical advances. Clinical trials serve to uncover better ways to treat, prevent, diagnose and understand human diseases. They provide mesothelioma researchers with critical information needed to allow them to move their findings from the lab to patients. They also offer patients access to a treatment that might not otherwise be available.

“I very much hope that our discovery will help save many lives,” said Angela Bononi, co-author of the study and post-doctoral fellow in Carbone’s lab.

Find the full study in the June 22, 2017 issue of Nature.

Know more about Mesothelioma and how you can deal with it.

How Paralegals Help with Your Mesothelioma Case

Paralegals can be found in every area of the law. One of the largest areas to utilize paralegals, though, is the personal injury field. Personal injury law is the field of law devoted to helping those who have been injured unjustly to seek compensation. For those who have been diagnosed with mesothelioma after being exposed to asbestos, compensation can be sought from the companies that failed to warn them of the danger.

Paralegals who work in the complex asbestos litigation field assist the attorneys who fight for the rights of victims who have been diagnosed with mesothelioma, asbestos lung cancer, asbestosis, and other asbestos diseases. These paralegals do a lot of behind-the-scenes work to help build the claim for maximum compensation, whether through litigation or asbestos bankruptcy funds.

Although many asbestos cases end in settlements, there are also many that go to trial, requiring a strong and experienced team of attorneys, paralegals, and other professionals. Paralegals assist attorneys in all aspects of asbestos litigation, from initial client interviews to appeals.

Common tasks performed by a paralegal for a mesothelioma case include:

Interviewing clients, doctors, medical specialists, and former co-workers or fellow veterans
Gathering medical records and other supporting evidence, such as documentation to pinpoint where and when the patient was exposed to asbestos
Aiding the attorney in determining what types of damages a plaintiff may be entitled to recover
Communicating with the client and insurance companies
Filing legal documents with the court
Locating expert witnesses to interview
Maintaining a calendar of pretrial and trial order deadlines
Preparing pretrial and trial motions

Asbestos litigation paralegals are specifically trained to work in this area of the law. Because of the complexities of mesothelioma cases, these legal professionals must possess a special set of skills and knowledge to assist attorneys and, ultimately, clients.

Ways paralegals help mesothelioma patients and their families pursue maximum compensation:

Client Services

Because asbestos attorneys are very busy and cannot perform every function necessary to successfully take on a case, paralegals provide extensive support involving client services. Paralegals help interview and screen potential clients, keep current with case status, and interact with clients and their families in a meaningful way to ensure their needs are being met.

Drafting

Asbestos paralegals must be skilled in drafting and submitting legal documents related to mesothelioma claims. Although the attorney ultimately reviews these documents, the paralegal spends the time drafting them and ensuring they are submitted on time.

Analysis

Paralegals must have specific training or experience in order to handle the medical aspects of a mesothelioma case. The paralegals will ascertain which medical records and bills are needed from the patient and determine what future cost projections or experts are needed. Many paralegals in this field are familiar with how asbestos diseases affect patients. This knowledge allows paralegals to prepare medical chronologies, medical expense itemizations, deposition summaries, and demand packages.

Trial Preparation

Asbestos litigation paralegals play an important role in trial preparation. They perform a variety of tasks to assist attorneys, including jury selection preparation, opening and closing statements, and witness outlines. Paralegals also determine which exhibits will be utilized and ensure that they are properly prepared for trial.

Trial

One of the paralegal’s main jobs is assisting the attorney(s) with the entire voir dire process, including taking notes and helping the attorney strike or select jurors. Once the trial is under way, paralegals pull and pass exhibits to the attorney, act as a liaison to the client, communicate with the bailiff or court reporter if issues arise, bring witnesses into the courtroom when it is their turn to testify, and act as a second set of eyes and ears in the courtroom.

Although this is not an exhaustive list of everything an asbestos litigation paralegal does to assist attorneys in mesothelioma cases, it certainly shows that paralegals play a pivotal role in helping clients pursue maximum compensation for their injuries. If you would like to learn more about the paralegal profession, visit Fremont College. The school’s website offers a number of resources for those looking for a career as a paralegal.

An ABA accelerated paralegal certificate program that allows you to finish your schooling in just 15 months. Robust education that speaks to essential skills needed for those looking to be successful in the legal field. Lean more about the Paralegal Studies program by visiting http://fremont.edu/ For more information, please visit us at www.fremont.edu or call us at 1-800-373-6668 / 1-800-FRE-MONT

Author: Nancy Meredith